Navigation Links
The 'febit science lounge' presents: Webinar About Role of Non-Protein-Coding RNA in Human Genome Set for 11 a.m. EDT on June 12

'The human genome as an RNA machine' with Prof. John Mattick with Institute

for Molecular Bioscience at University of Queensland, Australia

LEXINGTON, Mass. and HEIDELBERG, Germany, June 5 /PRNewswire/ -- febit holding gmbh today unveiled plans for the first of a series of educational Webinars geared for genomics researchers worldwide.

Moderated by febit's chief scientific officer, Peer Staehler, the first Webinar, which is set for 11 a.m. EDT on June 12, will feature John Mattick, Ph.D., a world-renowned researcher whose focus is the role of non-protein-coding ("junk") RNA in relation to the evolution and development of complex organisms.

"Genetic information that programs complex organisms lie in non-protein coding RNA," said Dr. Mattick, foundation professor of molecular biology and director of the Centre for Molecular Biology and Biotechnology, with the Institute for Molecular Bioscience at the University of Queensland, Australia. "This massive hidden network of regulatory information directs the precise patterns of gene expression during growth and development."

Mr. Staehler added: "This educational Webinar for the genomics researchers is the first of many to come. The team at febit is dedicated to support researchers to solve the challenge of understanding biological processes."

To participate in the Webinar, register at Please connect to the Webinar several minutes prior to the start time to ensure adequate time for any software download that may be necessary. The live event may also be accessed by dialing 877-715-5318 (for U.S. callers) and 973-582-2852 (for international callers) and entering conference ID 50057678. Questions may be asked over the telephone during the live event or e-mailed in advance to The Webinar will be available for replay for one year on febit's Web site.

About febit

febit enables scientists to read, write and understand the code of life: DNA. With its unique Geniom technology and services, febit is the only company that puts the control of simplified genomic research in the hand of the user. The seamless integration of DNA synthesis and analysis and the superior support in experiment design and bioinformatics helps to understand data and turn it into results. febit's team of experienced scientists is dedicated to support customers to solve the challenge of understanding biological processes. Geniom is a technological and service platform successfully implemented in basic and applied research by renowned institutions and companies. Geniom exploits cutting-edge microarray technology for analysis and synthesis of genes and genomes, providing superior time- and cost-efficiency combined with an unsurpassed spectrum of applications.


febit holding gmbh Russo Partners, LLC

Eva Sterzel David Schull or Wendy Lau

Public Relations Manager +1-212-845-4271

+49 (6221) 6510-300

SOURCE febit
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay
2. Penn scientist receives LOréal USA fellowship for women in science
3. Edwards Lifesciences to Present at the Goldman Sachs 29th Annual Global Healthcare Conference
4. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
5. Medical Simulation Corporation Announces Partnership With Seattle Science Foundation
6. Edwards Lifesciences Receives Additional Questions From the FDA About the LifeStent Product Line
7. New federally-funded health initiative to speed benefits of science to North Carolinians
8. Harvard Medical School receives major NIH grant for galvanizing translational science
9. BUMC, BMC receives Clinical and Translational Science Award from NIH
10. Experts to discuss sleep science and the health risks of sleep disorders in Baltimore this June
11. 1 small step for a lab science, 1 green leap for mankind
Post Your Comments:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. ... accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, ... and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
(Date:6/24/2016)... Norcross, Georgia (PRWEB) , ... June 24, 2016 ... ... Year” awards today at the Clinical Decision Making in Emergency Medicine conference in ... who have authored journal articles published in Emergency Medicine Practice and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
Breaking Medicine Technology: